Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Newstrike Brands Ltd NWKRF

Healthcare Biotechnology Cannabis
"Newstrike Brands Ltd is a licensed producer and cultivator of medical cannabis based in Brantford, Ontario. The company cultivates and sells both forms including dried and fresh marihuana."


OTCPK:NWKRF - Post by User

Newstrike Brands Ltd > Opinion and HIP CMED Synopsis
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3)
•••
Comment by Sevam123on Jan 12, 2018 2:59pm
71 Views
Post# 27344628

RE:RE:RE:RE:RE:RE:Opinion and HIP CMED Synopsis

RE:RE:RE:RE:RE:RE:Opinion and HIP CMED SynopsisThe shares are not at 80 cents right now because the market understands that CMED is worth way more than $24/share and is only trading at that level because of the ACB hostile takeover bid which goes away if they merge with HIP
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities